Detection of benzo(a)pyrene:DNA adducts in human white blood cells.

Metabolic activation of benzo(a)pyrene (BP) to its ultimate carcinogenic form, 7 beta, 8 alpha-diol-9 alpha, 10 alpha-benzo(a)pyrene epoxide (BPDE), and the binding of BPDE to DNA are important steps in BP carcinogenicity in experimental animals. Since people of certain occupations are exposed to high concentrations of BP, we have used enzyme-linked immunosorbent assay and ultrasensitive enzymatic radioimmunoassay to measure BPDE:DNA adducts in white blood cells from 2 of these occupational groups. Seven of 28 samples from roofers and 7 of 20 samples from foundry workers were positive for BPDE:DNA adducts (range, 2 to 120 fmol BPDE/50 micrograms DNA). In a group of nine volunteers without these industrial exposures to BP, the two positive DNA samples were from cigarette smokers. Control DNA obtained from human lymphocyte cell line RPMI 4265 was negative. These results indicate that the metabolic activation of BP and formation of BPDE:DNA adducts occurs in humans.

[1]  E. Miller.  Some current perspectives on chemical carcinogenesis in humans and experimental animals: Presidential Address. , 1978, Cancer research.

[2]  R. Yolken,et al.  Ultrasensitive enzymatic radioimmunoassay: application to detection of cholera toxin and rotavirus. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[3]  A. Hewer,et al.  The involvement of a diol‐epoxide in the metabolic activation of benzo(a)pyrene in human bronchial mucosa and in mouse skin , 1976, International journal of cancer.

[4]  F. Perera,et al.  A pilot project in molecular cancer epidemiology: determination of benzo[a]pyrene--DNA adducts in animal and human tissues by immunoassays. , 1982, Carcinogenesis.

[5]  E. Engvall,et al.  Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. , 1972, Journal of immunology.

[6]  I. Leck,et al.  Persons at High Risk of Cancer: An Approach to Cancer Etiology and Control , 1976, British Journal of Cancer.

[7]  A. Conney,et al.  Comparative metabolism of benzo[a]pyrene and drugs in human liver , 1977, Clinical pharmacology and therapeutics.

[8]  M. Guerin.  1 – Energy Sources of Polycyclic Aromatic Hydrocarbons* , 1978 .

[9]  W. Lijinsky,et al.  Benzo(a)pyrene and Other Polynuclear Hydrocarbons in Charcoal-Broiled Meat , 1964, Science.

[10]  A. Boobis,et al.  Carcinogenic benzo(a)pyrene metabolites bound to DNA: metabolic formation by human cultured lymphocytes and by human liver microsomes. , 1978, Pharmacology.

[11]  L. Smith,et al.  Binding of benzo [a]pyrene to epidermal DNA and RNA as detected by synchronous luminescence spectrometry at 77 K. , 1980, Journal of biochemical and biophysical methods.

[12]  C. Harris,et al.  Differences in Metabolism of Chemical Carcinogens in Cultured Human Epithelial Tissues and Cells , 1982, Journal of cellular biochemistry.

[13]  J. Higginson.  A hazardous society? Individual versus community responsibility in cancer prevention. Third annual Matthew B. Rosenhaus Lecture. , 1976, American journal of public health.

[14]  G. Cohen,et al.  Large interindividual variations in metabolism of benzo(α)pyrene by peripheral lung tissue from lung cancer patients , 1979, International journal of cancer.

[15]  R. Bast,et al.  Aryl hydrocarbon (benzo(a)pyrene) hydroxylase in human peripheral blood monocytes , 1974, Nature.

[16]  D G Hoel,et al.  Implication of nonlinear kinetics on risk estimation in carcinogenesis. , 1983, Science.

[17]  I. Weinstein,et al.  Quantitation of benzo(a)pyrene-deoxyguanosine adducts by radioimmunoassay. , 1980, Cancer research.

[18]  I. Weinstein,et al.  Monoclonal antibodies to DNA modified by a benzo[a]pyrene diol epoxide. , 1984, Carcinogenesis.

[19]  D. Nebert,et al.  Binding of polycyclic aromatic hydrocarbons to DNA: comparison with mutagenesis and tumorigenesis. , 1980, Journal of toxicology and environmental health.

[20]  M. Poirier.  Antibodies to carcinogen-DNA adducts. , 1981, Journal of the National Cancer Institute.

[21]  P. D. Lawley,et al.  Evidence for the Binding of Polynuclear Aromatic Hydrocarbons to the Nucleic Acids of Mouse Skin : Relation between Carcinogenic Power of Hydrocarbons and their Binding to Deoxyribonucleic Acid , 1964, Nature.

[22]  Dr Ferdiye Taner,et al.  The enzyme-linked immunosorbent assay (ELISA). , 1976, Bulletin of the World Health Organization.

[23]  R. Yolken,et al.  Measurement of benzo(a)pyrene-DNA adducts by enzyme immunoassays and radioimmunoassay. , 1981, Cancer research.

[24]  C. Harris,et al.  Interindividual variation in binding of benzo[a]pyrene to DNA in cultured human bronchi. , 1976, Science.

[25]  I J Selikoff,et al.  INHALATION OF BENZPYRENE AND CANCER IN MAN , 1976, Annals of the New York Academy of Sciences.